Related Experiment Videos
[Molecular biology of familial hypercholesterolemia]
Anales De Medicina Interna (Madrid, Spain : 1984)
|March 1, 1989
Insights
Familial hypercholesterolemia is a monogenic hereditary disease impacting the molecular level. Understanding its biochemical alterations has advanced diagnosis and treatment, clarifying its link to heart attacks.
Area of Science:
- Biochemistry
- Genetics
- Cardiovascular Medicine
Context:
- Familial hypercholesterolemia (FH) is a prevalent monogenic hereditary disorder.
- FH is a significant risk factor for premature acute heart infarction.
- The molecular basis of FH is crucial for understanding its clinical implications.
Purpose:
- To review the molecular causes and mechanisms of familial hypercholesterolemia production.
- To highlight the relationship between FH and acute heart infarction.
- To discuss advances in diagnosis and treatment based on biochemical knowledge.
Summary:
- This review examines the molecular underpinnings of familial hypercholesterolemia (FH).
- FH, a monogenic disorder, is directly linked to an increased risk of acute heart infarction.
- Profound knowledge of the biochemical alterations in FH has led to significant diagnostic and therapeutic progress.
Impact:
- Enhanced understanding of FH at the molecular level.
- Improved diagnostic strategies for identifying individuals with FH.
- Development of targeted treatments for managing FH and preventing cardiovascular events.
Abstract:
The causes and mechanisms of production of familial hypercholesterolemia at molecular level is reviewed. This is a monogenic hereditary disease that frequently affects the human being it is one of the supports in the existing relationship between hypercholesterolemia and acute heart infarction. Important advances in the diagnosis and treatment of this disease have been achieved with the profound knowledge of the biochemical alteration.